QT
SPRY icon

Quantbot Technologies’s ARS Pharmaceuticals SPRY Stock Holding History

Quantbot Technologies’s Portfolio SPRY Stock Details SPRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-8,126
Closed -$81.7K – 2147
2025
Q3 		$81.7K Buy
+8,126
New +$117K ﹤0.01% 1458
2024
Q2 		– Sell
-2,100
Closed -$21.5K – 1878
2024
Q1 		$21.5K Buy
+2,100
New +$15.7K ﹤0.01% 1403
2022
Q2 		– Sell
-5,421
Closed -$19K – 2105
2022
Q1 		$19K Sell
5,421
-2,500
-32% -$10.9K ﹤0.01% 1370
2021
Q4 		$52K Buy
+7,921
New +$64.4K ﹤0.01% 1014

Other funds holding SPRY

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Quantbot Technologies's SPRY Position: Q4 2025 in Review

Quantbot Technologies sold out of ARS Pharmaceuticals (SPRY) in Q4 2025, closing a stake of 8,126 shares — an estimated $81.7K sold.

Quantbot Technologies first reported a position in SPRY in Q4 2021 and held it in 4 quarters. The position peaked at $81.7K in Q3 2025. 189 funds tracked by Wall St. Rank hold SPRY as of Q4 2025.

  • Quantbot Technologies reported no remaining ARS Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Quantbot Technologies sold 8,126 ARS Pharmaceuticals shares in Q4 2025, an estimated $81.7K.
  • Quantbot Technologies first reported a position in ARS Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Quantbot Technologies's ARS Pharmaceuticals position peaked at $81.7K in Q3 2025.
  • 189 funds tracked by Wall St. Rank held ARS Pharmaceuticals as of Q4 2025.

Based on Quantbot Technologies's 13F filing for Q4 2025, filed 10 Feb 2026.